Home/Specialties/Proctology & Colorectal Surgery

Practice · Proctology & Colorectal Surgery

Discretion-first intake for a category that demands trust.

We build gastroenterologist and GP-network pathways for colorectal cancer, IBD surgery, complex fistula and haemorrhoid programmes — with intake designed around patient discretion.

For Chiefs of Colorectal Surgery, Coloproctology Consultants and MDs of GI super-specialties.

Request a Colorectal Pipeline Blueprint →Review case evidence

Screening → Colonoscopy

+184%

12-month cohort

Colorectal CA Case Volume

+128%

surgical resections

Discreet Intake Completion

72%

vs. 41% baseline

OT Utilization

78%

colorectal block

Procedure-level demand engineering

We target the procedures that move your P&L, not the ones that fill the OPD queue.

CATCHMENT TIER · PRICE RESTATEMENT

ARPU differs materially between Metro, Tier-2 and Tier-3 catchments. Switch tier to restate every procedure band against the payer mix and package ceilings we observe in that market — not a single all-India number.

Viewing Metro / Tier-1 · Representative catchments: Delhi NCR, Mumbai, Bengaluru, Chennai, Hyderabad, Kolkata, Pune.

Colorectal Cancer Resection

₹3.8 L–8.5 L

Screening + biopsy referral pathway

IBD Surgery (UC/Crohn's)

₹4.2 L–9.5 L

Long-cycle gastroenterology funnel

Complex Fistula Surgery

₹1.4 L–3.2 L

Recurrent-fistula second-opinion

Haemorrhoidectomy / MIPH

₹60K–1.4 L

Discreet day-care intake

Rectal Prolapse Repair

₹1.6 L–3.2 L

Elderly-population pathway

Pilonidal Sinus Surgery

₹50K–1.2 L

Young-adult recurrent-disease funnel

Methodology. Base bands reflect RDV's engagement dataset across 47 super-specialty hospitals, reconciled against CGHS/ECHS package rates, state-scheme ceilings (Ayushman Bharat PM-JAY, CMCHIS, YSR Aarogyasri) and empanelled TPA grids. Tier multipliers applied: Metro 1.00× · Tier-2 0.72× · Tier-3 0.55×. Actuals swing with payer mix, consultant-fee split and implant/consumable choice — the written Blueprint restates every band against your own HIS billing history before any spend is committed.

Clinical referral pathway

Intent → triage → consult → admission. Instrumented at every gate.

01 · Intent capture
Symptom, condition and referrer-based intent capture across catchment.
02 · Clinical triage
Specialty-trained nurse/coordinator triage with report upload before consult.
03 · Consultant handoff
Calendar-synced booking to the operating consultant with pre-read notes.
04 · Admission & OT slotting
CRM ↔ HIS tag: admission source, procedure code, OT date.

Case snapshot

2.3× resection volume, 72% discreet-intake completion.

A representative RDV engagement in the Proctology & Colorectal Surgery practice line. Individual results vary by catchment, clinical capacity and payer mix.

Setting: Colorectal unit inside GI super-specialty, 50 beds
Duration: 10 months
Cohort: n = 860 gastroenterology-referred cases
Outcome: 2.3× resection volume, 72% discreet-intake completion

Figures engagement-verified against hospital HIS. No outcome guarantees implied; per NMC advertising guidelines.

Why Chiefs of Colorectal choose RDV

Trust is earned in the operating logic, not the pitch deck.

Discretion-first UX

Intake designed for medical sensitivity — private-message channels, non-descript case numbers, no unsolicited outreach.

Gastroenterology MOU network

Colorectal growth flows through GI referrers. We build the network first, campaigns second.

Screening-programme rigour

Age-guideline-aligned colonoscopy screening. Never opportunistic, always evidence-based.

IBD MDT continuity

IBD patients enter a long-term multi-disciplinary pathway — generating retention revenue beyond the surgical episode.

From an engagement

"Our resection volume doubled while our patient-experience scores went up. The discreet-intake protocol earned trust in a category built on it."

— Chief of Colorectal Surgery · 50-bed GI super-specialty

Attribution anonymised per client confidentiality; engagement code verifiable in the founder-led review.

Talk directly to the founding partner who ran this engagement.

Request a Colorectal Blueprint →

48-hour founder-led review. Fixed-scope. No lock-in.

Clinical authority

Content your clinicians will co-sign.

Colorectal surgeon staging & MDT framework
IBD multi-disciplinary care library (gastro + surgery + nutrition)
Screening colonoscopy age-based guideline library

Compliance posture

Every asset, every claim, medically reviewed.

NMC norms — no comparative outcome claims for cancer surgery
Discretion-preserving intake and communication workflow
Screening-programme claims backed by NCCN/ESMO guideline alignment

Catchment note: Metropolitan screening catchments (50+ population) plus corporate-executive health corridors.

The 21-day diagnostic

What the fixed-scope engagement actually contains — for Colorectal.

No mystery, no scope creep. Each week is instrumented and delivered against a checklist your MD and Chief signs.

Week 1
Colorectal OT audit; screening-to-surgery leakage teardown.
Week 2
Gastroenterology and GP referrer catchment mapping.
Week 3
Procedure economics; IBD long-cycle retention model.
Week 4
Founder-led blueprint with Chief of Colorectal.

Where we compound

The unfair edge — for Colorectal specifically.

Discretion-first intake workflow — differentiator in a sensitive category
Gastroenterologist MOU network operational at metro scale
Age-cohort screening framework NCCN-aligned

Practice guarantees

What we commit to in writing.

Fixed-scope diagnostic — no retainer, no annual lock-in
HIS-verified attribution — every claimed admission traceable to source
No media markup — you see raw platform invoices at cost
Founder-led — the partner who scopes the engagement does the work

Objections we hear

The three questions MDs ask before signing.

We keep our answers on the record. If yours isn't here, ask it in the qualification form — the founding partner replies personally within 48 hours.

Colorectal is a private category — patients avoid marketing.

Which is why we build discretion into the intake and lead with gastroenterology referrals, not consumer ads.

Screening ROI is unclear.

In year one, yes. Screening becomes profitable as a resection funnel from month 12 onward. We model both timeframes explicitly.

Haemorrhoid volume is low-margin.

It's also your discretion-brand entry point. High-satisfaction day-care cases refer higher-margin work over 24 months.

FAQ

The questions Chiefs of Colorectal ask us first.

If yours isn't here, put it in the qualification form — our founding partner will answer it in the 48-hour review.

How do you preserve discretion in colorectal intake?+

Private-channel messaging, case-number-based communication, no unsolicited outreach and coordinator training on sensitive-category conversation.

Can you build gastroenterology MOU networks?+

Yes — this is the primary demand engine for colorectal. We codify the value exchange (joint MDT, outcome tracking, co-authored content) and operationalise it district by district.

What about international patients for IBD?+

IBD is a long-cycle international corridor. We build country-specific programmes with continuity of care, not one-off surgical tourism.

Next step